Inventor
NOMOTO KENICHI
JP18 patents
⚠️ This page may combine multiple inventors who share the name “NOMOTO KENICHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EISAI CO LTD
13 patentsUS5281626AJan 25, 1994
Benzenesulfonamide derivatives
EISAI CO LTD49 citations95
US5663414ASep 2, 1997
Benzenesulfonamide derivatives
EISAI CO LTD19 citations92
US5530118AJun 25, 1996
Benzenesulfonamide derivatives
EISAI CO LTD15 citations81
US4876262AOct 24, 1989
Piperidine derivative and pharmaceutical composition containing the same
EISAI CO LTD18 citations81
US5246946ASep 21, 1993
Piperidine derivatives and therapeutic and preventive agents for arrhythmia containing same
EISAI CO LTD6 citations73
US5179095AJan 12, 1993
Piperidine derivative and pharmaceutical composition containing the same
EISAI CO LTD11 citations73
US5118689AJun 2, 1992
Piperidine derivative and pharmaceutical composition containing the same
EISAI CO LTD5 citations73
US5541213AJul 30, 1996
Propenoic acid derivatives diazole propenoic acid compounds which have useful pharmaceutical utility
EISAI CO LTD8 citations71
US5162347ANov 10, 1992
Piperidine derivatives and therapeutic and preventive agents for arrhythmia containing same
EISAI CO LTD6 citations62
US5082850AJan 21, 1992
Piperidine derivatives and therapeutic and preventive agents for arrhythmia containing same
EISAI CO LTD4 citations62
US4996215AFeb 26, 1991
Piperidine derivative and pharmaceutical composition containing the same
EISAI CO LTD4 citations62
US5606073AFeb 25, 1997
Diazole-propenoic acid compounds
EISAI CO LTD4 citations60
US6649367B2Nov 18, 2003
Human cancer cell line malignantly altered by expression of angiogenic factor
EISAI CO LTD0 citations52
EISAI R&D MAN CO LTD
3 patentsUS11160783B2Nov 2, 2021
Multikinase inhibitors for use in the treatment of cancer
EISAI R&D MAN CO LTD0 citations60
US8937056B2Jan 20, 2015
Multikinase inhibitors for use in the treatment of cancer
EISAI R&D MAN CO LTD3 citations60
US9549922B2Jan 24, 2017
Use of eribulin and lenvatinib as combination therapy for treatment of cancer
EISAI R&D MAN CO LTD1 citations51